Network Activity

The role of partnerships in increasing the effectiveness of HIV, HCV and TB initiatives Panel

Date: Monday, November 3, 2014

Time: 3:15 – 4:45 p.m.

Location: Ottawa, ON at the 21st Canadian Conference on Global Health*

Organizer: The Canadian Society for International Health

The objective of this panel is to discuss the importance of partnerships, review the developed partnerships for projects currently being implemented, and review and discuss challenges, opportunities, and lessons learned. In addition, best practices and recommendations from implemented projects will be exchanged, as well as propositions and discussions on how partnerships can be enhanced to increase the value of implemented projects or programs.

The panel will be facilitated by World Hepatitis Alliance President, Charles Gore. Presenters at the panel include Marc-Andre Gaudreau from the Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada, Robin Montgomery from the Interagency Coalition on AIDS and Development, Dr. Curtis Cooper from the Department of Medicine at the University of Ottawa, and Andrew Matejcic from the Canadian Association for HIV Research.

Newcomer and Refugee Health Equity in HIV and Hepatitis C: From Research to Services

Date: Tuesday, November 4, 2014

Time: 10:30 a.m. – 12:00 p.m.

Location: Ottawa, ON at the 21st Canadian Conference on Global Health*

Organizer: The Canadian Society for International Health/The Interagency Coalition on AIDS and Development

The objective of this panel is to help better understand the state of newcomer and refugee health in Canada and in a global context, as well as to understand how being a newcomer has an impact on the health of people living with HIV and/or HCV and the environments in which they live or work that could put them at inequitable risk of HIV and/or HCV infection. In addition, the panel will explore partnerships that are helping to advance health equity for newcomers and refugee populations. The panel will also identify success stories, lessons learned, and research questions that will help guide future discussions and collaborations related to newcomer and refugee health, HIV/HCV co-infection in particular.

The panel will be facilitated by Janet Hatcher-Roberts, Technical Advisor for the Global HCV Network at CSIH, and Robin Montgomery from the Interagency Coalition on AIDS and Development. Speakers at the panel will include Dr. Alexander Klosovsky from the International Organization for Migration, Dr. Kevin Pottie from the Canadian Collaboration for Refugee and Immigrant Health at the University of Ottawa, Haoua Inoua from the AIDS Committee of Ottawa, Judith Odhiambo from the Committee for Accessible AIDS Treatment, and Lysane Blanchette-Lamothe, Member of Parliament and Official Opposition Critic for Citizenship and Immigration.

NOTE: This session will also be available via webcast. To register to attend the session via webcast, please contact sbuhler@icad-cisd.com.

*Registration for the CCGH is required for entry.

Access, Quality, Availability and Dignity of HCV Services Provided to Aboriginal Populations and People Living in Remote Areas

Date: November 27-28, 2014

Location: Thunder Bay, ON

Organizer: The Canadian Society for International Health/Elevate NWO

The workshop will intend to explore challenges faced in implementing prevention, diagnosis, treatment, and surveillance of HCV among Aboriginal and remote populations in Canada. In addition, the workshop will inform participants of best practices in terms of delivery of HCV services, and will discuss the role of public health and/or primary care professionals in the implementation of current guidelines and recommendations for HCV. The workshop is going to be organized as a series of plenary sessions as well as interactive activities. The workshop participants will work toward a recommendation to be presented to the Public Health Agency of Canada based on the findings from the workshop.

If this workshop interests you, please fill out the following form to register for the workshop in Thunder Bay, ON: https://www.surveymonkey.com/s/B3VKJQP.

 

HCV Treatment & Care in Vulnerable Populations: Challenges, Opportunities & Future Directions

Date: November 7th & 8th

Location: Ottawa, ON

Organizer: The Canadian Society for International Health

Funding Agency: The Public Health Agency of Canada & AbbVie

On November 7th & 8th, nearly 70 participants – policy analysts and decision makers, front-line workers, private industry representatives, and researchers – came together at the HCV Treatment & Care in Vulnerable Populations Workshop to present and discuss the anticipated impact of newer HCV medications for persons with HCV and HCV co-infections.

Armed with both policy level and ‘on the ground’ knowledge and expertise, Workshop participants were enthused to address the current and up-and-coming issues of HCV:

-HCV burden & its impact on vulnerable populations at a global, national, and local level

-Challenges & gaps in implementation of HCV testing and treatment management

-How HIV/AIDS lessons can be applied to HCV

While there was different opinions about how to best move forward in the anticipated ‘watershed moment’ of HCV treatment, there were some recurring themes throughout. There was continued acknowledgement, that in spite of newer treatments, social determinants of health will remain a factor for those affected by HCV and HCV co-infections. Side effects will be less of a hindrance to treatment management, but adherence will remain an issue for persons that continue to be burdened by poverty.

Repeated references were made to the Cascade of Care Model in HIV/AIDS Treatment and how it might be applied to HCV. One recommendation put forth was to add an earlier step that included “Who is your population at risk?” explaining that if we do not know the affected population well and what is needed, how can we offer optimal HCV care?

Also, ‘care’, unlike ‘testing’ and ‘diagnosis’ is not a standardized concept across Canada. We need to first come to an agreement as to what we mean by ‘care’ before moving forward.

It was also noted that primary care physicians need increased education about HCV, and when applicable, the opportunity for increased task uptake, particularly by physicians based in rural Canada. Lessons learned could be derived from such projects as the Extension for Community Health Care Outcomes (ECHO) model from the US.

CSIH would like to sincerely thank members of the Global HCV Network for presenting at this Workshop, as well as the multiple experts that came to share their expertise, representing a wide range of organizations: AbbVie, BC Centre for Excellence in HIV/AIDS, CDC, CDC China, CATIE, CTAC, Janssen Inc., Hemophilia Ontario, The Ottawa Hospital, Ontario Ministry of Health, Ontario Public Health, Pauktuutit Inuit Women of Canada, The Public Health Agency of Canada, Toronto Public Health, University of Alberta, University of Montreal, WHO, and many, many others.

The World Hepatitis Day Event

The Canadian Society for International Health, in collaboration with multiple organizations, organized a free BBQ in downtown Ottawa to mark World Hepatitis Day.

On July 27th, more than 350 people congregated at St. Paul’s Eastern United Church to learn more about viral hepatitis.

The event, led by CSIH, involved the participation of multiple organizations, including: the Public Health Agency of Canada, Ottawa Public Health, The Ottawa Hospital, Ottawa Inner City Health, Somerset West Community Health Centre, Canadian AIDS Society, Youth Services Bureau, The Canadian Liver Foundation, St. Paul’s Eastern United Church, and DUAL.

CSIH would like to sincerely thank organizations who made this event possible through financial and in-kind contributions: the Public Health Agency of Canada, Enbridge, Vertex Pharmaceuticals, Nate’s Deli, University of Ottawa, Cornerstone Bar and Grill, Best Buy Canada, and Boushey’s Grocery.

We would like to especially thank St. Paul’s Eastern United Church, Reverend Laurie McKnight-Walker and her congregation who were incredibly supportive and heavily involved in the planning process.

We thank the City of Ottawa for providing a Hepatitis Awareness Day Proclamation.

We would also like to thank the support of volunteers and event-goers for helping to make this World Hepatitis Day event a tremendous success! We sincerely hope to have your continued World Hepatitis Day support in the following years, and that you will join us in helping to bring further attention to this life-threatening disease.

For more information, please refer to CSIH’s site.

For more information about World Hepatitis Day activities in Canada, please visit the World Hepatitis Day in Canada site.

HIV/Viral Hepatitis (VH) Co-infection in Latin America and the Caribbean

Project Date:  July 21, 2012
Project Location: PAHO HQ, Washington, D.C.
Client/Partner: Pan American Health Organization (PAHO)
Funding Agency: Public Health Agency of Canada (PHAC) & Pan American Health Organization (PAHO)

Following the Regional Meeting on Viral Hepatitis, Bogotà, Colombia (March 2012), the Global HCV Network has been able to further strengthen its collaborative partnership with the Pan American Health Organization (PAHO) Headquarters. CSIH co-implemented a HIV/Viral Hepatitis co-infection satellite session with PAHO HQ on July 21st in Washington, D.C. as a lead-up to the International AIDS Conference.

The session opened with welcoming remarks by Dr. Jon Andrus, Deputy Director of PAHO, and primarily focused on the public health impact of HIV/VH co-infection, clinical management, and strategies for reducing prevalence.

Attended by leading experts in HIV/VH co-infection, presentations were given by: PAHO HQ (Washington, D.C.), The Ottawa Hospital (Ottawa, Canada), Centers for Disease Control and Prevention (Atlanta, USA), Brazil MOH (Brasíla, Brazil), Hepatitis Education Project (Seattle, USA), International Association of Physicians in AIDS Care (Chicago, USA), and WHO HQ (Geneva, Switzerland).

Members of the Global HCV Network presented on clinical management and public health impact of HIV/VH co-infection as well as HIV drug resistance prevention and assessment strategy. The satellite session was co-funded by the Public Health Agency of Canada (PHAC) and PAHO HQ. Sincere thanks to presenters, participants, and PAHO HQ for hosting this timely session.

Regional Meeting on Viral Hepatitis

Project Duration: 2011-2013
Project Location: Bogotá, Colombia
Client/Partner: Pan American Health Organization (PAHO)
Funding Agency: Public Health Agency of Canada (PHAC)

In collaboration with PAHO Headquarters (Washington, D.C.), CSIH co-implemented a Regional Meeting on Viral Hepatitis in Bogotá, Colombia from 1-2, March 2012.

More than 40+ participants from Ministries of Health, PAHO country offices, hospitals, and universities in the Latin American and Caribbean (LAC) region, as well as representatives from Centers for Disease Control (CDC), World Health Organization (WHO), and World Hepatitis Alliance, convened to review the context of viral hepatitis in the LAC region, burden of disease, regional priorities, and points of collaboration.

Specific meeting objectives were to:

1) review the current situation of viral hepatitis in the LAC region;

2) discuss PAHO/WHO’s work proposal on viral hepatitis; and

3) identify and determine regional priorities for collaboration.

LAC country representatives from Argentina, Brazil, Colombia, Cuba, Honduras, Jamaica, and Peru presented on surveillance, prevention, and control strategies of viral hepatitis within their respective countries, highlighting both lessons learned and proposed recommendations.

CSIH aims to continue working with PAHO HQ in bringing attention to viral hepatitis in LAC through ongoing knowledge exchange and dissemination as well as strengthening regional capacities through collaborative opportunities such as this meeting and World Hepatitis Day.

Advertisements